‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
MarketWatch作者：Jaimy Lee2026年10月13日查看原文 ↗ The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.